Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMhp Reg S Regulatory News (MHPC)

Share Price Information for Mhp Reg S (MHPC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.35
Bid: 3.26
Ask: 3.35
Change: 0.08 (2.45%)
Spread: 0.09 (2.761%)
Open: 3.35
High: 3.35
Low: 3.27
Prev. Close: 3.27
MHPC Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partial Execution of the Over-allotment Option by

5 Jan 2011 07:00

RNS Number : 9138Y
MHP S.A.
05 January 2011
 

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM THE RUSSIAN FEDERATION, UKRAINE, THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

05 January 2011

MHP S.A.

 

Announces Partial Execution of the Over-allotment Option by Joint Bookrunners of the Equity Offering

 

MHP S.A. ("MHP" or the "Company", LSE ticker: "MHPC"), one of the leading agro-industrial companies in Ukraine, focusing on the production of poultry and the cultivation of grain, announces today that during the over-allotment option period the Joint Bookrunners exercised in part their option to purchase 1,429,668 GDRs, representing approximately $23.6 million in gross proceeds. As a result, an aggregate of approximately 11.4 million GDRs were sold in connection with this offering. All GDRs were sold at $16.50 per GDR, resulting in a total offering size of approximately $188.6 million. The over-allotment option period has closed and no additional shares will be sold pursuant to the over-allotment option.

 

All of the GDRs in the offering, including the GDRs subject to the over-allotment option, were sold by WTI Trading Limited (the "Selling Shareholder"). The Company did not receive any proceeds from the sale of the shares in connection with this secondary offering. The Selling Shareholder, a limited liability company organised under the laws of Cyprus, is beneficially owned by Yuriy Kosiuk, the controlling beneficial shareholder and CEO of the Company.

 

In connection with the transaction, the Company and the Selling Shareholder have agreed to a 180 day lock-up arrangement.

 

Morgan Stanley and UBS Investment Bank acted as Joint Bookrunners for the Offering.

 

ENQUIRIES

MHP Investor Relations

Anastasiia Sobotiuk Kyiv: +38 044 207 99 58

Financial Dynamics

Ben Foster (London)

Marc Cohen (London)

Leonid Solovyev (Moscow)

 

 

London: +44 20 7831 3113

 

Moscow: +7 495 795 06 23

 

 

 

 

 

Important Notice

Morgan Stanley & Co International plc and UBS Limited, each of which is authorised and regulated in the UK by the Financial Services Authority, are acting exclusively for the Company and, in respect of only the sale of GDRs, the Selling Shareholder and no one else in connection with the Offering and will not regard any other person (whether or not a recipient of this announcement) as their respective clients and will not be responsible to anyone other than the Company and the Selling Shareholder for providing the protections afforded to clients of Morgan Stanley & Co. International plc and UBS Limited nor for giving advice in relation to the Offering, the contents of this announcement or any transaction or arrangement referred to herein.

 

The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "Securities Act") or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in the United Kingdom or any other European Economic Area state, Australia, Canada, Japan, Ukraine, the Russian Federation, or the United States. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada, Japan, Ukraine or the Russian Federation or any other jurisdiction. There will be no public offer of the securities in the United States or elsewhere.

 

This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom (subject to applicable laws), (ii) to investment professionals falling within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (iii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "Relevant Persons"). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this document or any of its contents. Persons distributing this document must satisfy themselves that it is lawful to do so.

 

In connection with the offering, Morgan Stanley & Co. International plc (the "Stabilizing Manager") (or persons acting on behalf of the Stabilizing Manager) may (but is under no obligation to) effect transactions in the GDRs with a view to supporting the market price of the GDRs at a level higher than that which might otherwise have prevailed in the open market. However, there is no assurance that the Stabilizing Manager (or persons acting on behalf of the Stabilizing Manager) will undertake stabilization action. Any stabilization action may begin on or after the date on which adequate public disclosure of the final price of the global depositary receipts is made and, if begun, may be ended at any time, but it must end no later than 30 days after the date of such adequate public disclosure of the final price of the GDRs. Any stabilization action must be conducted by the Stabilizing Manager (or person(s) acting on behalf of the Stabilizing Manager) in accordance with all applicable laws and rules. Save as required by law or regulation, neither the Stabilizing Manager nor any of its agents intends to disclose the extent of any stabilization transactions conducted in relation to the Offering.

 

This document is an advertisement and is not a prospectus for the purposes of EU Directive 2003/71/EC (the "Prospectus Directive") and Part VI of the Financial Services and Markets Act 2000 (the "FSMA"). In any EEA Member State that has implemented the Prospectus Directive this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.

 

In connection with the Offering, Morgan Stanley & Co. International plc or UBS Limited, or any of their respective affiliates, acting as investors for their own accounts, may subscribe for or purchase GDRs and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such GDRs and other securities of the Company or related investments in connection with the Offering or otherwise. Accordingly, references to the GDRs being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by Morgan Stanley & Co. International plc or UBS Limited or any of their respective affiliates acting as investors for their own accounts. Morgan Stanley & Co. International plc and UBS Limited do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

 

The offer and the distribution of this press release and other information in connection with the offer in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

 

This announcement and information contained therein are for information purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. Information in this announcement cannot be relied upon as a guide to future performance. The price and value of securities may go up as well as down. Persons needing advice should contact a professional adviser.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGGMLDMGMZM
Date   Source Headline
2nd May 20247:30 amRNS2023 Integrated Annual Report and Press Statement
11th Mar 20241:02 pmRNSEGM Results
7th Feb 202412:41 pmRNSEGM- Convening Notice
23rd Jan 20249:54 amRNSAppointment of a new ARC Chair
16th Nov 20237:13 amRNSQ3 and 9M 2023 Financial Results
25th Sep 20239:02 amRNSFinancial Statement Q2 2023
21st Sep 20237:06 amRNSDate Notification Q2 2023 Results
8th Sep 20237:00 amRNSMHP SE Invests in Saudi Arabia
19th Jun 20238:41 amRNSAGM results
18th May 20237:00 amRNSQ1 2023 Financial and Operational Results
17th May 202311:00 amRNSAGM Convening Notice
11th Apr 20239:42 amRNSMHP SE Standalone FS 2022
11th Apr 20239:27 amRNSMHP SE Standalone FS 2022
11th Apr 20238:54 amRNSMHP SE Standalone 2022
11th Apr 20237:00 amRNS2022 Integrated Annual Report
21st Mar 202311:07 amRNSDate Notification - Date Change
7th Mar 202310:24 amRNSEGM results
16th Feb 20231:54 pmRNSMHP and Tanmiah - announcement of a partnership
2nd Feb 20237:25 amRNSConvening Notice - EGM
25th Jan 20237:53 amRNSMonthly Operational Update - December 2022
17th Jan 20234:41 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Dec 20227:00 amRNSMonthly Operational Update - November 2022
25th Nov 20228:00 amRNSMonthly Operational Update - October 2022
16th Nov 20227:00 amRNSQ3 and 9M 2022 Financial and Operational Results
25th Oct 20227:00 amRNSMonthly Operational Update - September
23rd Sep 20227:19 amRNSOperational Monthly Update - August 2022
14th Sep 20227:00 amRNSQ2 and H1 2022 Financial Results
2nd Sep 202212:40 pmRNSDate Change Notification
19th Aug 202210:20 amRNSOperational Monthly Update - July 2022
9th Aug 20224:41 pmRNSSecond Price Monitoring Extn
9th Aug 20224:36 pmRNSPrice Monitoring Extension
27th Jul 20227:13 amRNSQ2 and H1 2022 Pre close trading update
22nd Jul 20227:21 amRNSOperational Monthly Update - June 2022
30th Jun 20222:22 pmRNS2021 MHP Sustainability Report
24th Jun 20227:27 amRNSMHP Monthly Update - May 2022
17th Jun 20227:56 amRNSQ1 2022 Financial Results
24th May 20227:44 amRNSMonthly Operational Update for April 2022
17th May 202212:25 pmRNSAGM - Convening Notice
5th May 202212:06 pmRNSSeparate FS
5th May 202210:57 amRNSFinancial Results for the Q4 and 12M 2021
28th Apr 202210:16 amRNSDate notification
22nd Apr 20229:43 amRNSPre-Close TU for the Q1 2022
11th Apr 202210:48 amRNSMHP - Operational Update
30th Mar 20223:55 pmRNSConsent Solicitation - Results Announcement
23rd Mar 20221:40 pmRNSUpdate Announcement - Consent Solicitation
21st Mar 202210:49 amRNSMHP - Consent Solicitation Announcement
18th Mar 20221:57 pmRNSCoupon Payment Information
14th Mar 20229:41 amRNSDamage to Warehouse - Loss of Produce
10th Mar 20228:26 amRNSMHP - SUPPORT FOR UKRAINE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.